China SXT Pharmaceuticals, Inc. Amended Reports
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-05-19: Form 20-F/A; Period of report 2022-03-31; Description AMENDMENT NO. 1 TO FORM 20-F; Document f20f2022a1_chinasxtphar.htm.
- 2019-08-19: Form 20-F/A; Period of report 2019-03-31; Description AMENDMENT NO. 1 TO FORM 20-F; Document f20f2019a1_chinasxtpharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-05-19 | 20-F/A | 2022-03-31 | AMENDMENT NO. 1 TO FORM 20-F | f20f2022a1_chinasxtphar.htm |
| 2019-08-19 | 20-F/A | 2019-03-31 | AMENDMENT NO. 1 TO FORM 20-F | f20f2019a1_chinasxtpharma.htm |